49 results
Page 2 of 3
8-K
EX-99.1
pqzfa30x 3d
5 Nov 19
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7:15am
8-K
EX-10.1
2k91z6
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
yu45qknrl
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-1.1
e13ky0wku
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm